The company initially filed for Chapter 11 bankruptcy protection in February. At that time the company asked the court to continue business practices and a potential sale of assets during the bankruptcy process, according to SEC filings.
InVivo Therapeutics’ implants are designed for patients with acute thoracic spinal cord injuries, according to its website.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
